483
Versiti Indiana IncFDA 483 - Versiti Indiana Inc - May 07, 2019
Record Details
An FDA inspection of Versiti Indiana Inc, a blood bank in Indianapolis, revealed significant deficiencies in equipment maintenance, labeling, record-keeping, and adherence to standard operating procedures for HCT/Ps and blood products. Issues included unmaintained cryogenic freezers, improperly labeled tissues, unrecorded storage temperatures, and missing or incomplete documentation for processing and distribution steps. These observations indicate a lack of control over critical processes impacting product quality and traceability.
Open in Dashboard
ID · 4b39e8da-04cc-4902-9542-1a53ca0a7a74